UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2020
Commission File Number: 001-38396
BIOFRONTERA AG
(Registrant’s name / Translation of registrant’s name into English)
Hemmelrather Weg 201, D-51377 Leverkusen Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form:40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A
This disclosure on form 6-k is made following new rules regarding disclosure of related party transactions in the EU. On 01.01.2020 Sections 111a to 111c of the German Stock Corporation Act became effective in Germany. These provisions contain rules for related party transactions. These provisions are based on the amendment of Directive2007/36/EC through Directive (EU )2017/828of the European Parliament and the Council of the European Union. Among other things, the provisions stipulate that transactions with related parties must be disclosed under certain conditions in accordance with section 111c of the German Stock Corporation Act.
EXHIBITS
Exhibit Number | Description | |
99.1 | Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BIOFRONTERA AG | ||
By: | /s/ Hermann Lübbert | |
Name: | Hermann Lübbert | |
Title: | Chief Executive Officer | |
By: | /s/ Thomas Schaffer | |
Name: | Thomas Schaffer | |
Title: | Chief Financial Officer |
Date: March 12, 2020